Liverpool’s St George’s Hall will be seen in a new light next week as it supports a group of campaigners and sufferers, raising awareness of the facial condition, trigeminal neuralgia.
On Tuesday 7 October from dusk until 10pm, St George’s Hall will be bathed in a steel blue coloured light in support of an international group which is trying to make as many people aware of this little known condition.
Trigeminal neuralgia (TN, or TGN), is a neuropathic disorder which results in episodes of intense pain the face, originating from the trigeminal nerve.
Councillor Roz Gladden, cabinet member for Adult Social Care and Health said: “I am delighted that the city of Liverpool and St George’s Hall have got involved in raising awareness of this painful condition.
“Many people are unaware that trigeminal neuralgia exists and this is an ideal way for TNNME, an international awareness group, to inform people and hopefully gain support for more funding and research to be given to those suffering from this condition.
“I hope the support we offer today will go some way to ensuring their message is heard.”
Julie Carmichael from Trigeminal Neuralgia and me (TNNME) said: “I am delighted that Liverpool City Council is supporting our ‘Light up Teal’ day this year.
“It is vital that we try and get as much information and support for those suffering daily from this devastating condition.”
St George’s Hall will be one of many buildings across the world taking part in the second annual ‘light up’ campaign. Buildings and bridges from China to Canada, Niagara to New York will also be lit.
The University of Liverpool will also light up its engineering building. Other landmarks in the UK getting involved include, The Gateshead Millennium Bridge in Newcastle and Trafalgar Square fountain.
Trigeminal neuralgia has been described as among the most painful conditions known to humankind and it is estimated that 1 in 15,000 people suffer from it, although the actual figure may be significantly higher due to frequent misdiagnosis.
In the majority of cases, symptoms begin appearing more frequently over the age of 50, although there have been instances where patients as young as three years of age have been diagnosed. It is also more common in females than males.